DYRK1A and Dravet syndrome: EGCG inhibits DYRK1A overexpression, a gene involved in a range of routes associated to neural progenitor cell growth, and the primary gene candidate to explain DS phenotype [124]; treatment with EGCG may normalize its overproduction improving behavioral and neural phenotypes in this condition.